$3.34
0.3411.33%
At Close: -
$3.33
-0.0100-0.30%
After Hours: Sep 20, 4:24 PM EDT
15 minutes delayed
OncoCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of OncoCyte using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.36 | $-0.56 | 35.7 % |
Mar 2024 | 2024-05-15 | $-1.13 | $-0.67 | -68.7 % |
Mar 2024 | 2024-04-12 | $-2.18 | $-1.14 | -91.2 % |
Sep 2023 | 2023-11-09 | $-0.50 | $-1.01 | 50.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $104.00K | $320.00K | -67.5 % |
Mar 2024 | 2024-05-15 | $176.00K | $350.00K | -49.7 % |
Mar 2024 | 2024-04-12 | $314.00K | $320.00K | -1.88 % |
Sep 2023 | 2023-11-09 | $429.00K | $330.00K | 30.0 % |
OncoCyte (OCX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.36, which beat the estimate of $-0.56.
The Actual Revenue was $104K, which missed the estimate of $320K.
Browse earnings estimates, EPS, and revenue on all stocks.